Gynesonics
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- $201M
Investors
- 13
About Gynesonics
Founded in 2005 in Redwood City, US, Gynesonics, Inc. specializes in women's health solutions, primarily addressing uterine fibroids. The company's previous founders include experienced leaders in the medical device sector.00 mn, with Hologic, Inc.Gynesonics specializes in developing transcervical, uterus-preserving, incisionless technologies aimed at improving women's health, particularly in the treatment of symptomatic uterine fibroids. The company's flagship product, the Sonata System, is the first and only intrauterine fibroid ablation system that utilizes ultrasound guidance combined with targeted radiofrequency energy. This innovative procedure is designed to provide a safe, effective alternative to traditional surgical techniques such as hysterectomy or myomectomy, offering patients a less invasive option for managing heavy periods caused by fibroids.Gynesonics generates revenue primarily through the sale of its medical devices, specifically the Sonata System, to healthcare facilities and providers. The transaction structure typically involves direct sales to hospitals and outpatient surgical centers, where the technology is integrated into women's health practices. By offering a unique, incisionless solution, Gynesonics positions itself favorably within the medical device market, focusing on partnerships with healthcare providers that emphasize patient care and safety. The revenue model may include pricing agreements tied to the volume of devices purchased, supported by ongoing customer training and product support services to enhance the end-user experience., which was completed on October 14, 2024, Gynesonics aims to leverage this acquisition to enhance treatment options available to women suffering from heavy periods and fibroids. Plans include the launch of new products designed to further improve treatment methodologies, with specific details to be announced in early 2025. The acquisition will facilitate expansion into wider geographic markets, particularly in North America and Europe, to meet the increasing demand for advanced gynecological solutions.
Who invested in Gynesonics
13 investors across 7 rounds
See all investors in Gynesonics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 2, 2023
Amount
$43M
Investors
Series A
Apr 6, 2023
Amount
$25M
Investors
Series F
Dec 18, 2018
Amount
$75M
Investors
Series D
Feb 20, 2013
Amount
$22M
Investors
Series C
May 10, 2010
Amount
$16M
Investors
Series B
Jan 24, 2007
Amount
$17M
Investors
Series A
Nov 9, 2005
Amount
$3.9M
Investors
Questions about Gynesonics
Who invested in Gynesonics?
Gynesonics has 13 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gynesonics raised?
Gynesonics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Gynesonics last raise money?
Gynesonics's most recent round on record is a Series A, in Nov 2023.
What does Gynesonics do?
Founded in 2005 in Redwood City, US, Gynesonics, Inc.
Where is Gynesonics headquartered?
Gynesonics is headquartered in Redwood City, US.
Which VCs invest in companies like Gynesonics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Gynesonics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Gynesonics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.